1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow Pulmonary Emphysema: new trials by email Literature Review of Pulmonary Emphysema trials Research Report on Pulmonary Emphysema
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD) Alpha-1 15%, Liquid Alpha1-PI - Alpha 1 Antitrypsin Deficiency | Phase 3 | Recruiting | Grifols Therapeutics LLC | 40 | 2026-05-05 | 2026-10-26 |
Emphysema (1) · Genetic Diseases, Inborn (1) · Lung Diseases (1) · Lung Diseases, Obstructive (1) · Pathologic Processes (1) · Pulmonary Disease, Chronic Obstructive (1) · Respiratory Tract Diseases (1) · Subcutaneous Emphysema (1) · alpha 1-Antitrypsin Deficiency (1)
Chronic Disease (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Digestive System Diseases (1) · Disease Attributes (1) · Liver Diseases (1) · Pathological Conditions, Signs and Symptoms (1)
15-keto-17-phenyl-18,19,20-trinorprostaglandin F2 alpha-1-isopropyl ester (1)
Denmark (1) · Germany (1) · Ireland (1) · Netherlands (1) · Poland (1) · Portugal (1) · Spain (1) · Sweden (1) · United States (1)
2025 (1)